Updated Recommendation
A new evidence synthesis was published:2015, Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB- and HIV-prevalence settings – 2015 update
View latest version (2015)Bibliographic Info
Recommendation
Recommended in favor
Conditional
Certainty of evidence
Moderate
Adults and adolescents living with HIV who have an unknown or positive TST status and who are unlikely to have active TB should receive at least 36 months of Isoniazid preventive therapy (IPT). IPT should be given to such individuals irrespective of the degree of immunosuppression, and also to those on ART, those who have previously been treated for TB and pregnant women
Also Featured In
This recommendation also appears in the following guidelines:
WHO policy on collaborative TB/HIV activities : guidelines for national programmes and other stakeholders
Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB- and HIV-prevalence settings – 2015 update
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Latent tuberculosis infection: updated and consolidated guidelines for programmatic management
WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.
WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities.
WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities, 2nd ed.